1 |
Randomized controlled trial/ |
2 |
Controlled clinical study/ |
3 |
Random$.ti,ab. |
4 |
randomization/ |
5 |
intermethod comparison/ |
6 |
placebo.ti,ab. |
7 |
(compare or compared or comparison).ti. |
8 |
(open adj label).ti,ab. |
9 |
((double or single or doubly or singly) adj (blind or blinded or blindly)).ti,ab. |
10 |
double blind procedure/ |
11 |
parallel group$1.ti,ab. |
12 |
(crossover or cross over).ti,ab. |
13 |
((assign$ or match or matched or allocation) adj5 (alternate or group$1 or intervention$1 or patient$1 or subject$1 or participant$1)).ti,ab. |
14 |
(assigned or allocated).ti,ab. |
15 |
(controlled adj7 (study or design or trial)).ti,ab. |
16 |
(volunteer or volunteers).ti,ab. |
17 |
trial.ti. |
18 |
or/1‐17 |
19 |
exp breast cancer/ |
20 |
breast cancer$.tw,sh. |
21 |
advanced breast cancer$.tw,sh. |
22 |
advanced breast carcinoma$.tw,sh. |
23 |
advanced breast neoplasm$.tw,sh. |
24 |
advanced breast tumo?r$.tw,sh. |
25 |
exp metastatic breast cancer/ |
26 |
metastatic breast cancer$.tw,sh. |
27 |
metastatic breast carcinoma$.tw,sh. |
28 |
metastatic breast neoplasm$.tw,sh. |
29 |
metastatic breast tumo?r$.tw,sh. |
30 |
exp triple negative breast cancer/ |
31 |
triple negative breast cancer$.tw,sh. |
32 |
Triple Negative Breast carcinoma$.tw,sh. |
33 |
Triple Negative Breast neoplasm$.tw,sh. |
34 |
Triple Negative Breast tumo?r$.tw,sh. |
35 |
or/21‐34 |
36 |
(19 or 20) and 35 |
37 |
exp cisplatin/ |
38 |
exp carboplatin/ |
39 |
exp platinum complex/ |
40 |
exp platinum/ |
41 |
exp oxaliplatin/ |
42 |
exp platinum derivative/ |
43 |
platinum containing regime*.tw. |
44 |
(platin* or diamminedicholoroplatinum or cis‐diamminedichloroplatinum or cis‐dichlorodiammineplatinum or biocisplatinum or dichlorodiammineplatinum or nsc‐119875 or platidiam or paraplatin or cis‐platinum or carboplatinum or cyclobutanedicarboxylato or jm‐8 or cbdca or nsc‐241240).mp. |
45 |
(Carboplatin or Blastocarb or Carboplat or Carboplatin Hexal or Carboplatino or Carbosin or Carbosol or Carbotec or CBDCA or Displata or Ercar or Nealorin or Novoplatinum or Paraplat or Paraplatin AQ or Paraplatin or Paraplatine or Platinwas or Ribocarbo).mp. |
46 |
(Cisplatin or Abiplatin or Blastolem or Briplatin or CACP or CDDP or cis‐DDP or cis‐diamminedichloridoplatinum or cis‐diamminedichloro platinum II or cis‐diamminedichloroplatinum or Cis‐dichloroammine Platinum II or Cismaplat or Cisplatina or cisplatinous diamine dichloride or cis‐platinum II diamine dichloride or cis‐platinum II or cis‐platinum or Cisplatyl).mp. |
47 |
(Citoplatino or Citosin or CPDD or Cysplatyna or DDP or Lederplatin or Metaplatin or Neoplatin or PDD or Peyrone's Chloride or Peyrone's Salt or Placis or Platamine or Platiblastin or Platiblastin‐S or Platinex or Platinol‐AQ or Platinol or Platinol‐ AQ VHA Plus or Platinol‐AQ or Platinoxan or platinum diamminodichloride or Platiran or Platistin or Platosin).mp. |
48 |
(Oxaliplatin or Ai Heng or Aiheng or diaminocyclohexane oxalatoplatinum or oxalatoplatin or oxalatoplatinum or oxaliplatine or Eloxatin or Dacotin or Dacplat or Eloxatine or 1‐OHP or L‐OHP or oxaliplatin medac).mp. |
49 |
or/37‐48 |
50 |
18 and 36 and 49 |
51 |
limit 50 to (human and (conference abstracts or embase)) |